UVDI Joins APIC to Counter Misinformation and Uplift Science During International Infection Prevention Week

To raise awareness about the importance of infection prevention and the essential role infection preventionists (IPs) play in public health, UVDI, the leading manufacturer of advanced Ultraviolet technology for Hospital Room Disinfection and Indoor Air Quality, is joining the Association for Professionals in Infection Control and Epidemiology (APIC) as a Corporate Sponsor for International Infection Prevention Week (IIPW), October 17–23.

UVDI has introduced several new educational resources for safe, effective UV room disinfection to emphasize the science behind infection prevention, the misinformation that continues to circulate, and how to inspire the next generation of IPs to join the fight. Educational Resources include a series of new Continuing Education webinars including Fact Versus Fiction: Clarifying Myths Regarding UV Room Disinfection, and three whitepapers sharing UV Basics and Beyond. All are accessible on UVDI’s online Learning Hub at www.uvdi.com.

As IPs continue to protect communities from surges in COVID-19 cases and healthcare-associated infections (HAIs), it has never been clearer just how crucial infection prevention and control is to everyone’s health and safety. In recognition of the role that everyone should play in infection prevention, the 2021 IIPW theme is “Make Your Intention Infection Prevention.” APIC has developed downloadable infographics, fact sheets, and social media materials to help educate all audiences on infection prevention and control—the science behind it and its legitimacy as a trusted profession in the healthcare space.

“We honor the dedication and selflessness of Infection Prevention professionals – this week and every week,” said Peter Veloz, CEO, UVDI. “Working with APIC to provide fact-based evidence and resources for safe, effective UV disinfection is a core part of our ongoing commitment to better patient outcomes.”

“We are happy to have UVDI join our other Corporate Sponsors for this year’s International Infection Prevention Week,” said APIC President Ann Marie Pettis, RN, BSN, CIC, FAPIC. “With their help, we are able to reach consumers and other healthcare personnel about how they can make their intention infection prevention.”

UVDI plans to join APIC and other healthcare organizations on Tuesday, October 19 at 12 PM ET for a Twitter chat using #IIPWChat to discuss the impacts of COVID-19, how to counter misinformation with facts, and what it looks like to be an IP. Learn more at www.InfectionPreventionandYou.org/iipw.

SourceUVDI
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy